Na Jiao

2.6k total citations · 1 hit paper
49 papers, 1.6k citations indexed

About

Na Jiao is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Na Jiao has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Epidemiology and 11 papers in Genetics. Recurrent topics in Na Jiao's work include Gut microbiota and health (22 papers), Inflammatory Bowel Disease (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). Na Jiao is often cited by papers focused on Gut microbiota and health (22 papers), Inflammatory Bowel Disease (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). Na Jiao collaborates with scholars based in China, United States and Australia. Na Jiao's co-authors include Ruixin Zhu, Lixin Zhu, Robert J. Genco, Michael Buck, Maria Tsompana, Susan S. Baker, Colleen A. Nugent, Robert D. Baker, Wensheng Liu and Lucy D. Mastrandrea and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Na Jiao

46 papers receiving 1.5k citations

Hit Papers

Suppressed hepatic bile acid signalling despite elevated ... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers

Na Jiao
Hao Ren China
Chuangen Li Hong Kong
Jing Guan China
Yin Yin China
Astrid Kosters United States
Hao Ren China
Na Jiao
Citations per year, relative to Na Jiao Na Jiao (= 1×) peers Hao Ren

Countries citing papers authored by Na Jiao

Since Specialization
Citations

This map shows the geographic impact of Na Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Jiao more than expected).

Fields of papers citing papers by Na Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Jiao. The network helps show where Na Jiao may publish in the future.

Co-authorship network of co-authors of Na Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Na Jiao. A scholar is included among the top collaborators of Na Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Jiao. Na Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Ruixin, Wei Wang, Wenxing Gao, et al.. (2025). Multimodal metagenomic analysis reveals microbial InDels as superior biomarkers for pediatric Crohn’s disease. Journal of Crohn s and Colitis. 19(4). 2 indexed citations
2.
Li, Yichen, Wenxia Wang, Ruixin Zhu, et al.. (2025). STAT1 mediates the pro-inflammatory role of GBP5 in colitis. Communications Biology. 8(1). 385–385. 2 indexed citations
3.
Gao, Wenxing, Ruixin Zhu, Liwen Tao, et al.. (2024). Systematic identification of secondary bile acid production genes in global microbiome. mSystems. 10(1). e0081724–e0081724. 4 indexed citations
4.
Jiao, Na, Lixin Zhu, & Ruixin Zhu. (2024). The search for authentic microbiome–disease relationships. Nature Medicine. 30(5). 1243–1244. 1 indexed citations
5.
Xu, Pingping, Ruixin Zhu, Wenxing Gao, et al.. (2024). Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis. Communications Biology. 7(1). 24–24. 13 indexed citations
6.
Gao, Wenxing, Xiang Gao, Lixin Zhu, et al.. (2023). Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer. Gut Microbes. 15(2). 2245562–2245562. 17 indexed citations
7.
Gao, Xiang, Ruicong Sun, Na Jiao, et al.. (2023). Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn’s disease. Cell Reports Medicine. 4(6). 101050–101050. 27 indexed citations
8.
Xu, Tingjun, Wenxing Gao, Lixin Zhu, et al.. (2023). NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease. Journal of Chemical Information and Modeling. 64(7). 2817–2828. 2 indexed citations
9.
Zhou, Chenfen, Na Jiao, Xinling Liang, et al.. (2023). Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy. Microbiology Spectrum. 11(3). e0520222–e0520222. 7 indexed citations
10.
Li, Xiaoyi, Dingfeng Wu, Wenxing Gao, et al.. (2023). Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer. Physiological Genomics. 56(2). 221–234. 6 indexed citations
11.
Wu, Dingfeng, Lei Liu, Na Jiao, et al.. (2022). Targeting keystone species helps restore the dysbiosis of butyrate‐producing bacteria in nonalcoholic fatty liver disease. SHILAP Revista de lepidopterología. 1(4). e61–e61. 30 indexed citations
12.
Jiao, Na, Xiao Ke, Lixin Zhu, & Ruixin Zhu. (2022). Evidence challenging the causal role of gut microbiota in inflammatory bowel diseases. Gastroenterology report. 11. goad064–goad064. 2 indexed citations
13.
Jiao, Na, Rohit Loomba, Zihuan Yang, et al.. (2021). Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD. Physiological Genomics. 53(8). 336–348. 20 indexed citations
14.
Li, Yichen, Jie Li, Jia Ke, et al.. (2021). Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study. Frontiers in Medicine. 8. 604263–604263. 10 indexed citations
15.
He, Zhen, Junli Gong, Jia Ke, et al.. (2021). Microbiota in mesenteric adipose tissue from Crohn’s disease promote colitis in mice. Microbiome. 9(1). 228–228. 37 indexed citations
16.
Wu, Dingfeng, Wenxing Gao, Chuan Tian, et al.. (2020). Dr AFC : drug repositioning through anti-fibrosis characteristic. Briefings in Bioinformatics. 22(3). 8 indexed citations
17.
Cheng, Sijing, Dingfeng Wu, Jie Li, et al.. (2020). Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study. Respiratory Research. 21(1). 277–277. 12 indexed citations
18.
Zhang, Qian, Chuan Tian, Chun Li, et al.. (2019). The roles of Qishen granules recipes, Qingre Jiedu, Wenyang Yiqi and Huo Xue, in the treatment of heart failure. Journal of Ethnopharmacology. 249. 112372–112372. 14 indexed citations
19.
Sun, Yi, Ruixin Zhu, Na Jiao, et al.. (2015). Functional Cross-Talking between Differentially Expressed and Alternatively Spliced Genes in Human Liver Cancer Cells Treated with Berberine. PLoS ONE. 10(11). e0143742–e0143742. 10 indexed citations
20.
Jiao, Na. (2008). Attribute Reduction Based on Binary Granules and Granular Computing. Journal of Guangxi Normal University. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026